VENTYX BIOSCIENCES INC (VTYX) Fundamental Analysis & Valuation
NASDAQ:VTYX • US92332V1070
Current stock price
14 USD
+0.02 (+0.14%)
At close:
13.99 USD
-0.01 (-0.07%)
After Hours:
This VTYX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. VTYX Profitability Analysis
1.1 Basic Checks
- VTYX had negative earnings in the past year.
- VTYX had a negative operating cash flow in the past year.
- In the past 5 years VTYX always reported negative net income.
- In the past 5 years VTYX always reported negative operating cash flow.
1.2 Ratios
- VTYX's Return On Assets of -50.41% is on the low side compared to the rest of the industry. VTYX is outperformed by 63.73% of its industry peers.
- VTYX has a Return On Equity (-55.71%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.41% | ||
| ROE | -55.71% | ||
| ROIC | N/A |
ROA(3y)-49.18%
ROA(5y)-2852.36%
ROE(3y)-54.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VTYX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. VTYX Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, VTYX has more shares outstanding
- The number of shares outstanding for VTYX has been increased compared to 5 years ago.
- VTYX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 25.06 indicates that VTYX is not in any danger for bankruptcy at the moment.
- VTYX has a Altman-Z score of 25.06. This is amongst the best in the industry. VTYX outperforms 90.16% of its industry peers.
- There is no outstanding debt for VTYX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 25.06 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 17.86 indicates that VTYX has no problem at all paying its short term obligations.
- VTYX has a better Current ratio (17.86) than 89.12% of its industry peers.
- VTYX has a Quick Ratio of 17.86. This indicates that VTYX is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 17.86, VTYX belongs to the top of the industry, outperforming 89.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.86 | ||
| Quick Ratio | 17.86 |
3. VTYX Growth Analysis
3.1 Past
- VTYX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.44%, which is quite impressive.
EPS 1Y (TTM)36.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 9.83% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25.5%
EPS Next 2Y5.91%
EPS Next 3Y1.01%
EPS Next 5Y9.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. VTYX Valuation Analysis
4.1 Price/Earnings Ratio
- VTYX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VTYX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.91%
EPS Next 3Y1.01%
5. VTYX Dividend Analysis
5.1 Amount
- No dividends for VTYX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VTYX Fundamentals: All Metrics, Ratios and Statistics
14
+0.02 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-19 2026-03-19/amc
Inst Owners84.42%
Inst Owner Change19.9%
Ins Owners4.22%
Ins Owner Change-21.51%
Market Cap1.00B
Revenue(TTM)N/A
Net Income(TTM)-106.61M
Analysts70.67
Price Target13.64 (-2.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.41%
Min EPS beat(2)20.73%
Max EPS beat(2)30.09%
EPS beat(4)4
Avg EPS beat(4)24.4%
Min EPS beat(4)20.73%
Max EPS beat(4)30.09%
EPS beat(8)8
Avg EPS beat(8)19.04%
EPS beat(12)9
Avg EPS beat(12)10.5%
EPS beat(16)12
Avg EPS beat(16)11.87%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.34%
EPS NY rev (1m)0%
EPS NY rev (3m)0.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.25 | ||
| P/tB | 5.25 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.5
EYN/A
EPS(NY)-1.74
Fwd EYN/A
FCF(TTM)-1.22
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS0
BVpS2.67
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.41% | ||
| ROE | -55.71% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-49.18%
ROA(5y)-2852.36%
ROE(3y)-54.31%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -20.8% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 17.86 | ||
| Quick Ratio | 17.86 | ||
| Altman-Z | 25.06 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)216.42%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
EPS Next Y25.5%
EPS Next 2Y5.91%
EPS Next 3Y1.01%
EPS Next 5Y9.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.12%
EBIT Next 3Y5.59%
EBIT Next 5YN/A
FCF growth 1Y45.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.88%
OCF growth 3YN/A
OCF growth 5YN/A
VENTYX BIOSCIENCES INC / VTYX Fundamental Analysis FAQ
What is the ChartMill fundamental rating of VENTYX BIOSCIENCES INC (VTYX) stock?
ChartMill assigns a fundamental rating of 3 / 10 to VTYX.
What is the valuation status for VTYX stock?
ChartMill assigns a valuation rating of 0 / 10 to VENTYX BIOSCIENCES INC (VTYX). This can be considered as Overvalued.
How profitable is VENTYX BIOSCIENCES INC (VTYX) stock?
VENTYX BIOSCIENCES INC (VTYX) has a profitability rating of 0 / 10.
How financially healthy is VENTYX BIOSCIENCES INC?
The financial health rating of VENTYX BIOSCIENCES INC (VTYX) is 8 / 10.